Safety and Efficacy of GSMs-TACE Combined With Surgical Resection in the Treatment of Hepatocellular Carcinoma (HCC) With Type III Portal Vein Tumor Thrombus (PVTT)

Hepatocellular Carcinoma (HCC) With Type III Portal Vein Tumor Thrombus (PVTT) Clinical Trial

Official title: Safety and Efficacy of GSMs-TACE Combined With Surgical Resection in the Treatment of Hepatocellular Carcinoma (HCC) With Type III Portal Vein Tumor Thrombus (PVTT): A Single Center, Open, Randomized Controlled Trial.

Status Recruiting

Clinical Trial Summary

A Single center, Open, Randomized Controlled Trial Evaluating the Safety and Efficacy of GSMs-TACE Combined with Surgical Resection in the Treatment of Hepatocellular Carcinoma (HCC) with Type III Portal Vein Tumor Thrombus (PVTT).

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Carcinoma
• Carcinoma, Hepatocellular
• Hepatocellular Carcinoma (HCC) With Type III Portal Vein Tumor Thrombus (PVTT)
• Thrombosis

• NCT number: NCT04619342
• Study type: Interventional
• Source: Beijing Tsinghua Chang Gung Hospital
• Contact: Yuewei Zhang
• Phone: 00861800115669
• Email: zhangyuewei1121@sina.com.cn
• Status: Recruiting
• Phase: N/A
• Start date: October 30, 2020
• Completion date: December 31, 2022